A detailed history of Ascent Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 8,960 shares of AMGN stock, worth $2.51 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
8,960
Previous 8,993 0.37%
Holding current value
$2.51 Million
Previous $2.81 Million 2.78%
% of portfolio
0.41%
Previous 0.41%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $10,209 - $11,133
-33 Reduced 0.37%
8,960 $2.89 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $43,091 - $52,366
164 Added 1.86%
8,993 $2.81 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $1.37 Million - $1.65 Million
5,088 Added 136.01%
8,829 $2.51 Million
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $30,684 - $34,615
120 Added 3.31%
3,741 $1.08 Million
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $791,731 - $982,956
3,621 New
3,621 $973,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.